Clinical Trial Update: Olaparib Maintenance Therapy in Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating olaparib as maintenance therapy in metastatic breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Olaparib (Olaparib)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Metastatic Breast Cancer | Phase 2 | Status: UNKNOWN